The market for brain supplements is expected to grow by US $4,020.62m in the next four years – driven largely by an ageing global population. Thriving...
Models of care should consider the unique and sustained burden of dementia, authors say.
Global healthcare company, Eisai, is collaborating with a leading US university to research potential new treatments for Alzheimer’s and Parkinson’s disease. The Japan-based pharmaceutical company and...
Europe’s largest provider of digital-first home healthcare, Cera, is further investing in its technology and data insights as winter approaches. Cera, a digital-first home healthcare company...
With the right infrastructure in place, patients can now receive high-quality, safe, hospital-level care in the comfort of their homes.
